A Report on the Anthropometric and Health Characteristics of Foreign Students at SRBIAU in 2023-2024
الموضوعات : Food and Health
Amirfaham Rezaee
1
,
Niloofar Bayat
2
,
Mahsa Aghaei
3
,
Melika Sajadhosseini
4
,
Melika Tahmasbi
5
,
Behnood Abbasi
6
1 - Electronic Health and Statistics Surveillance Research Center, Science and Research Branch
2 - Electronic Health and Statistics Surveillance Research Center, Science and Research Branch
3 - Electronic Health and Statistics Surveillance Research Center, Science and Research Branch
4 - Electronic Health and Statistics Surveillance Research Center, Science and Research Branch
5 - Electronic Health and Statistics Surveillance Research Center, Science and Research Branch
6 - Electronic Health and Statistics Surveillance Research Center, Science and Research Branch
الکلمات المفتاحية: Anthropometric Characteristics, Health Risks, Obesity, Physical Activity, Metabolic Disorders,
ملخص المقالة :
This study aims to assess the anthropometric and health characteristics of foreign students at the Science and Research Branch of Islamic Azad University in Tehran, Iran, during the 2023-2024 period. A total of 400 non-Iranian students participated in this cross-sectional study. Anthropometric measurements, including weight, height, BMI, waist circumference, and body composition, were taken using standardized equipment. Physical activity levels, blood pressure, fasting blood sugar, and heart rate were also assessed. The results revealed a significant prevalence of overweight and obesity (21.75%), particularly among females (31.93%), and high rates of hypertension and prediabetes. The study found a high proportion of sedentary individuals (70.6%), which is a key contributor to the observed health risks. These findings highlight the importance of addressing obesity-related health issues, particularly in the context of non-communicable diseases (NCDs), and their economic impact. This data is crucial for the development of targeted health policies, such as medical tourism and insurance adjustments for individuals at higher health risks. The study concludes that proactive measures are essential to prevent and manage the health conditions prevalent in this population.
1.Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-42.
2.Golubnitschaja O, Liskova A, Koklesova L, Samec M, Biringer K, Busselberg D, et al. Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021. EPMA J. 2021;12(3):243-64.
3.Hoque ME, Mannan M, Long KZ, Al Mamun A. Economic burden of underweight and overweight among adults in the Asia-Pacific region: a systematic review. Trop Med Int Health. 2016;21(4):458-69.
4.Collaborators GBDRF. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-49.
5.Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31(1):219-30.
6.Cuntz U, Quadflieg N, Voderholzer U. Health Risk and Underweight. Nutrients. 2023;15(14).
7.Kwon H, Yun JM, Park JH, Cho BL, Han K, Joh HK, et al. Incidence of cardiovascular disease and mortality in underweight individuals. J Cachexia Sarcopenia Muscle. 2021;12(2):331-8.
8.Flammer Syndrome. In: Golubnitschaja O, editor. Advances in Predictive, Preventive and Personalised Medicine. 11: Springer Cham. p. XII, 376.
9.Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2010;316(2):104-8.
10.Beland D, Zarzeczny A. Medical tourism and national health care systems: an institutionalist research agenda. Global Health. 2018;14(1):68.
11.Crooks VA, Kingsbury P, Snyder J, Johnston R. What is known about the patient's experience of medical tourism? A scoping review.
12.Kim DH, Sheppard CE, de Gara CJ, Karmali S, Birch DW. Financial costs and patients' perceptions of medical tourism in bariatric surgery. Can J Surg. 2016;59(1):59-61.
13.Snyder J, Crooks VA, Johnston R, Kingsbury P. What do we know about Canadian involvement in medical tourism?: a scoping review. Open Med. 2011;5(3):e139-48.
14.Horowitz MD, Rosensweig JA, Jones CA. Medical tourism: globalization of the healthcare marketplace. MedGenMed. 2007;9(4):33.
15.Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102-38.
16.Arnett Donna K, Blumenthal Roger S, Albert Michelle A, Buroker Andrew B, Goldberger Zachary D, Hahn Ellen J, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Journal of the American College of Cardiology. 2019;74(10):e177-e232.
17.Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011;8:115.
18.Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology. 2018;71(19):e127-e248.
19.Committee ADAPP. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024. Diabetes Care. 2023;47(Supplement_1):S20-S42.
20.Okati-Aliabad H, Ansari-Moghaddam A, Kargar S, Jabbari N. Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis. J Obes. 2022;2022:8074837.
21.Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16(3):177-89.
22.Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377(1):13-27.
23.Musaiger AO. Overweight and obesity in eastern mediterranean region: prevalence and possible causes. J Obes. 2011;2011:407237.
24.Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet. 2012;380(9838):247-57.
25.Balouchi A, Rafsanjani M, Al-Mutawaa K, Naderifar M, Rafiemanesh H, Ebadi A, et al. Hypertension and Pre-Hypertension in Middle East and North Africa (MENA): A Meta-Analysis of Prevalence, Awareness, Treatment, and Control. Curr Probl Cardiol. 2022;47(7):101069.
26.Yusufali AM, Khatib R, Islam S, Alhabib KF, Bahonar A, Swidan HM, et al. Prevalence, awareness, treatment and control of hypertension in four Middle East countries. J Hypertens. 2017;35(7):1457-64.
27.Ali S, Zhen L, Hassan S. Chronic kidney disease associated with hypertension. World Journal of Biology Pharmacy and Health Sciences. 2023;16:194-9.
28.Shenasa M, Shenasa H. Hypertension, left ventricular hypertrophy, and sudden cardiac death. Int J Cardiol. 2017;237:60-3.
29.Masenga SK, Kirabo A. Hypertensive heart disease: risk factors, complications and mechanisms. Front Cardiovasc Med. 2023;10:1205475.
30.Johansson BB. Hypertension mechanisms causing stroke. Clin Exp Pharmacol Physiol. 1999;26(7):563-5.
31.Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17(9):961-9.
32.Florez JC, Hirschhorn J, Altshuler D. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet. 2003;4:257-91.
33.Khattab A, Javaid A, Iraqi G, Alzaabi A, Ben Kheder A, Koniski ML, et al. Smoking habits in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012;106 Suppl 2:S16-24.
34.Lonardo A, Adinolfi LE, Petta S, Craxì A, Loria P. Hepatitis C and diabetes: the inevitable coincidence? Expert Rev Anti Infect Ther. 2009;7(3):293-308.
35.Gomaa A, Allam N, Elsharkawy A, El Kassas M, Waked I. Hepatitis C infection in Egypt: prevalence, impact and management strategies. Hepat Med. 2017;9:17-25.
36.Yang T, Qi F, Guo F, Shao M, Song Y, Ren G, et al. An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory. Molecular Medicine. 2024;30(1):71.
37.Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719-24.
38.Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-7.
39.Flores MD, del Carmen Cortés Ginez M, Gutman LAB. Biochemical Mechanisms of Vascular Complications in Diabetes. In: Rodriguez-Saldana J, editor. The Diabetes Textbook: Clinical Principles, Patient Management and Public Health Issues. Cham: Springer International Publishing; 2023. p. 795-811.
40.Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52.
41.Anjana RM, Mohan V, Rangarajan S, Gerstein HC, Venkatesan U, Sheridan P, et al. Contrasting Associations Between Diabetes and
8 Rezaee et al. / Food & Health 2024, 7(2): 1-8
Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study. Diabetes Care. 2020;43(12):3094-101.
42.Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-22.
43.Lewis GF, Steiner G. Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care. 1996;19(4):390-3.
44.Sparks JD, Sparks CE, Adeli K. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2012;32(9):2104-12.
45.Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886-99.
46.Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46(6):733-49.
47.Ho KL, Karwi QG, Connolly D, Pherwani S, Ketema EB, Ussher JR, Lopaschuk GD. Metabolic, structural and biochemical changes in diabetes and the development of heart failure. Diabetologia. 2022;65(3):411-23
